Barry Canton is > 10% Shareholder of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 12.4 Million shares of DNA, which is worth approximately $77.1 Million. The most recent transaction as insider was on Feb 03, 2023, when has been sold 156,382 shares (Class A Common Stock) at a price of $2.13 per share, resulting in proceeds of $333,093. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.4M
0% 3M change
4.09% 12M change
Total Value Held $77.1 Million

Barry Canton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2023
SELL
Open market or private sale
$333,093 $2.13 p/Share
156,382 Reduced 1.06%
14,544,866 Class A Common Stock
Feb 02 2023
SELL
Open market or private sale
$81,700 $2.17 p/Share
37,650 Reduced 0.26%
14,701,248 Class A Common Stock
Feb 01 2023
SELL
Open market or private sale
$295,878 $1.91 p/Share
154,910 Reduced 1.04%
14,738,898 Class A Common Stock
Jan 31 2023
SELL
Open market or private sale
$276,674 $1.85 p/Share
149,554 Reduced 0.99%
14,893,808 Class A Common Stock
Jan 30 2023
SELL
Open market or private sale
$294,862 $1.89 p/Share
156,012 Reduced 1.03%
15,043,362 Class A Common Stock
Jan 27 2023
SELL
Open market or private sale
$265,550 $1.82 p/Share
145,907 Reduced 0.95%
15,199,374 Class A Common Stock
Jan 26 2023
SELL
Open market or private sale
$334,213 $1.77 p/Share
188,821 Reduced 1.22%
15,345,281 Class A Common Stock
Jan 25 2023
SELL
Open market or private sale
$274,634 $1.73 p/Share
158,748 Reduced 1.01%
15,534,102 Class A Common Stock
Jan 24 2023
SELL
Open market or private sale
$280,269 $1.82 p/Share
153,994 Reduced 0.97%
15,692,850 Class A Common Stock
Jan 23 2023
SELL
Open market or private sale
$251,664 $1.75 p/Share
143,808 Reduced 0.9%
15,846,844 Class A Common Stock
Jan 20 2023
SELL
Open market or private sale
$254,182 $1.67 p/Share
152,205 Reduced 0.94%
15,990,652 Class A Common Stock
Jan 19 2023
SELL
Open market or private sale
$339,733 $1.7 p/Share
199,843 Reduced 1.22%
16,142,857 Class A Common Stock
Jan 18 2023
SELL
Open market or private sale
$301,852 $1.95 p/Share
154,796 Reduced 0.94%
16,342,700 Class A Common Stock
Jan 17 2023
SELL
Open market or private sale
$281,847 $1.86 p/Share
151,531 Reduced 0.91%
16,497,496 Class A Common Stock
Jan 13 2023
SELL
Open market or private sale
$278,999 $1.77 p/Share
157,627 Reduced 0.94%
16,649,027 Class A Common Stock
Jan 12 2023
SELL
Open market or private sale
$327,389 $1.72 p/Share
190,343 Reduced 1.12%
16,806,654 Class A Common Stock
Jan 11 2023
SELL
Open market or private sale
$234,318 $1.6 p/Share
146,449 Reduced 0.85%
16,996,997 Class A Common Stock
Jan 10 2023
SELL
Open market or private sale
$236,697 $1.5 p/Share
157,798 Reduced 0.91%
17,143,446 Class A Common Stock
Jan 09 2023
SELL
Open market or private sale
$231,281 $1.52 p/Share
152,159 Reduced 0.87%
17,301,244 Class A Common Stock
Jan 06 2023
SELL
Open market or private sale
$226,620 $1.49 p/Share
152,094 Reduced 0.86%
17,453,403 Class A Common Stock
Jan 05 2023
SELL
Open market or private sale
$280,544 $1.54 p/Share
182,172 Reduced 1.02%
17,605,497 Class A Common Stock
Dec 23 2022
SELL
Open market or private sale
$333,492 $1.64 p/Share
203,349 Reduced 1.13%
17,787,669 Class A Common Stock
Dec 22 2022
SELL
Open market or private sale
$347,579 $1.66 p/Share
209,385 Reduced 1.15%
17,991,018 Class A Common Stock
Dec 21 2022
SELL
Open market or private sale
$328,460 $1.7 p/Share
193,212 Reduced 1.05%
18,200,403 Class A Common Stock
Dec 20 2022
SELL
Open market or private sale
$678,553 $1.66 p/Share
408,767 Reduced 2.17%
18,393,615 Class A Common Stock
BC

Barry Canton

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA